So if you're taking one of these new drugs and the scale doesn't seem to be budging, you may be wondering what's going on
If the decision is made to continue topiramate despite persistent acidosis, alkali treatment should be considered
If those options are out of reach, Trava is one of several reasonable compounded providers, and the entry-level semaglutide pricing is genuinely competitive
Clinical trials have shown that patients taking Wegovy (semaglutide) at the maintenance dose of 2.4mg lost an average of 15% to 21% of their body weight over 68 weeks when combined with diet and exercise
GLP-1 and GLP-1/GIP medication options may include Tirzepatide, Semaglutide, Zepbound, Mounjaro, Wegovy, and Ozempic when clinically appropriate